Apheresis Market

Apheresis Market Size (2022 to 2027)

The global apheresis market size is estimated to grow USD 3.54 billion by 2027 from USD 2.2 billion in 2022, showcasing a CAGR of 9.96% during the forecast period.

Apheresis Market Share Insights:

• Based on product, the disposables segment dominated the market in 2021.
• Based on procedure, the therapeutic segment held major share of the global apheresis market in 2021.
• Based on application, the neurology segment occupied the leading share of the market in 2021.
• Based on technology, the centrifuge segment led the market in 2021.
• North America dominated the market in 2021 and accounted for the largest share.
• The European region is expected to be valued at USD 760 million by 2027.
• The Asia-Pacific region is anticipated to grow at a CAGR of 12.58% from 2022 to 2027.

Apheresis removes the blood from the donor or patient and sends it to an apparatus that separates one constituent and returns the remainder to the body. The procedure involves connecting the blood in the patient's vein through tubing to a machine that separates the blood components. After the separation, the desired blood component is taken, while the rest of the blood components are reinforced back into the patient.

MARKET DRIVERS:

In recent years, apheresis procedures have observed a rise in the number and areas of applications, and the apheresis market for these procedures continues to increase at an unprecedented pace. Currently, apheresis procedures are used as a part of treatment in various renal diseases, neurology, cancer, hematology, autoimmune diseases, and cardiovascular diseases. Several private and public insurers have begun to observe the apheresis reimbursement procedure. Many private insurers provide coverage for apheresis procedures regardless of whether they are conducted in a hospital. Similar policy-related reforms are implemented in other countries and insurers consensus on wide coverage of diseases.

Rising prevalence of various blood disorders and the growing number of trauma and injury cases, the increasing demand for blood components, and growing concerns regarding blood safety across the globe, increasing demand for source plasma from biopharmaceutical companies increasing the number of surgical procedures and emergency care cases in hospitals. The presence of favorable government initiatives and reimbursement framework is also expected to boost demand during the forecast period.

MARKET RESTRAINTS:

However, the growth of the global apheresis market is restrained by the lack of awareness about apheresis, a limited number of skilled professionals, and the high cost of these procedures.

Impact of COVID-19 on the global apheresis market:

The outrage of recent coronavirus (COVID 19) has led to significant and rapid healthcare industry changes. The World Health Organization (WHO) announced the pandemic as public health emergency issue. Many of the hospitals and clinics have shut their doors temporarily during the lockdown period. The medical professionals who are in the front line battling the COVID 19 need to take precautionary measures to prevent the disease's spread. The COVID-19 has negatively impacted the apheresis market growth during the first half of the pandemic situation. Amidst the crisis, none of the patients have visited the hospitals and clinics to be safe and protect themselves from the virus. The professionals have taken severe measures to collect any blood components from patients or donors to avoid the infection. The healthcare professionals have re-started their work in organizing blood either from the patients or donors that may be used during emergencies. The growth of the global apheresis market is expected to pick the pace up owing to the resuming of the activities by performing surgical procedures. In addition, considering the reducing impact of COVID-19 and growing habituation towards the new normalization, the apheresis market is anticipated to showcase a healthy growth rate during the forecast period.

REPORT COVERAGE:

This research report on the global apheresis market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2027.

Apheresis Market - By Product:

• Devices
• Disposables

The disposable segment is predicted to lead the global apheresis market during the forecast period based on the product. Many advancements in the manufacturing of blood bags, tubing, and disposable kits are expected to fuel the segmental growth. The escalating efficacy in the ability to separate all types of blood components via the therapeutic procedure is another favorable factor for the growth of the segment during the forecast period.

Apheresis Market - By Procedure:

• Donor
• Therapeutic
• Photopheresis

Based on the procedure, the therapeutic apheresis segment is projected to register a healthy growth rate due to the growing therapeutic use for different neurology, blood, and renal diseases, increasing incidence of blood disorders, and acceptable reimbursement policies for apheresis methods.

On the other hand, the plasmapheresis accounted for considerable share of the global market in 2021 and is expected to continue holding strong foothold in the coming years.

Apheresis Market – By Application:

• Renal Diseases
• Neurology
• Cancer
• Hematology
• Autoimmune Diseases
• Cardiovascular Diseases

Based on the application, the neurology segment is expected to account for the largest share in the market during the forecast period due to the benefits associated, such as low blood loss and reduced treatment duration, and complete automation.

The hematology segment is estimated to grow at the fastest rate due to the increasing stress of hematology occurrence.

Apheresis Market – By Technology:

• Centrifuge
• Membrane Separation

Based on the technology, the centrifuge apheresis segment is the most lucrative. The primary usage of centrifuges majorly drives this segment's growth for the preparation of blood components such as packed red blood cells and fresh frozen plasma.

The membrane separation segment is expected to have rapid growth during the forecast period as it requires less time and prevents lessening of blood coagulation factors, limiting the demand for replacement fluids.

Apheresis Market – By End User:

• Private Blood Collection Centres
• Public Blood Collection Centres
• Hospitals

Based on the end-user, the private and public blood collection centers segment is expected to dominate the market. The increasing number of blood component donations, growing blood centers, and rising awareness of blood collection are majorly supporting the segmental growth.

Apheresis Market – By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Geographically, the apheresis market in North America outranked other regions and accounted for the majority share of the global apheresis market in 2021. It is forecasted that North American will be continuing leading the market throughout the forecast period. The large share of this region can be attributed to the presence of developed healthcare systems in the U.S. & Canada, increasing applications of apheresis products in plasma collection and fractionation, the presence of established distribution channels, and growing focus on apheresis blood collection to overcome blood shortage.

The Europe apheresis market is anticipated to hold substantial share of the worldwide market during the forecast period.

The apheresis market in Asia Pacific is the fastest-growing market because countries such as Japan and emerging economies such as India and China are projected to witness exponential growth during the forecast period.

The Latin American apheresis market is anticipated to grow at a steady CAGR during the forecast period.

The apheresis market in MEA is expected to hold a moderate share of the global market in the coming years.

KEY MARKET PARTICIPANTS:

Some of the companies that are playing a dominating role in the global apheresis market profiled in the report are Asahi Kasei Medical Co., Ltd., Haemonetics Corporation, Terumo BCT, Inc., Fresenius Medical Care, Kawasumi Laboratories Inc., Cerus Corporation, HemaCare Corporation, Kaneka Corporation, B. Braun Melsungen AG, and Nikkiso Co., Ltd., Therakos, Inc., and Medica S.p.A.